Oscar Health Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Mark Bertolini
Chief executive officer
US$44.5m
Total compensation
CEO salary percentage | 1.0% |
CEO tenure | 1.8yrs |
CEO ownership | n/a |
Management average tenure | 3.6yrs |
Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Investors Give Oscar Health, Inc. (NYSE:OSCR) Shares A 25% Hiding
Dec 20Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Stock Yet As It Plummets 27%
Oct 29Not Many Are Piling Into Oscar Health, Inc. (NYSE:OSCR) Just Yet
Sep 13Oscar Health: At Nearly 4x Book Value Investors Should Wait For A Pullback
Sep 03Oscar Health: Achieves Profitability In Q1 2024, But Uncertainties Remain
Jul 02Results: Oscar Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
May 11Investors Still Aren't Entirely Convinced By Oscar Health, Inc.'s (NYSE:OSCR) Revenues Despite 30% Price Jump
May 03Oscar Health: Strong Industry Catalyst With Margin Expansion Potential
Apr 13This Analyst Just Made An Upgrade To Their Oscar Health, Inc. (NYSE:OSCR) Earnings Forecasts
Feb 12Oscar Health, Inc. (NYSE:OSCR) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Feb 10Oscar Health: Flexible Business Model Is Paying Off
Jan 30Further Upside For Oscar Health, Inc. (NYSE:OSCR) Shares Could Introduce Price Risks After 37% Bounce
Jan 19Oscar Health, Inc. (NYSE:OSCR) Soars 49% But It's A Story Of Risk Vs Reward
Nov 21Oscar Health: Q3 Earnings Suggest Growth Can Continue Into 2024
Nov 15Oscar Health: Decreasing Memberships Is Worrying
Sep 22Oscar Health Shares Quadrupled, But They Are Still Cheap
Jul 03Oscar Health: High Growth And Improving Profitability Make It A Buy
Jun 15Oscar Health Insurance GAAP EPS of -$1.05 beats by $0.03, revenue of $995M misses by $415M
Feb 09Oscar Health: Wait For Concrete Evidence The Business Can Turn Profitable
Jan 18Oscar Health Is Back On Track
Nov 11Oscar Health: Improving Risk/Reward Profile To Watch
Oct 03Florida health insurer terminating agreement with Oscar Health
Aug 30CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | US$29m |
Jun 30 2024 | n/a | n/a | US$18m |
Mar 31 2024 | n/a | n/a | -US$54m |
Dec 31 2023 | US$45m | US$450k | -US$271m |
Compensation vs Market: Mark's total compensation ($USD44.54M) is above average for companies of similar size in the US market ($USD6.66M).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
CEO
Mark Bertolini (67 yo)
1.8yrs
Tenure
US$44,540,814
Compensation
Mr. Mark Thomas Bertolini serves as CEO & Director of Oscar Health, Inc. (formerly known as Mulberry Health Inc.). He is an Advisor at Wisdom Ventures Fund, LLC. He was Co-Chief Executive Officer of Bridge...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 1.8yrs | US$44.54m | no data | |
Co-Founder | 12.3yrs | US$854.00k | 1.5% $ 53.0m | |
Chief Financial Officer | 1.4yrs | US$6.20m | 0.37% $ 13.1m | |
Chief Legal Officer | 3yrs | US$3.19m | 0.098% $ 3.5m | |
Executive VP & Chief Insurance Officer | no data | US$5.75m | 0.21% $ 7.3m | |
Co-Founder & Vice Chairman | 3.9yrs | no data | no data | |
Chief Operating Officer | no data | no data | 0.042% $ 1.5m | |
Chief Accounting Officer | 3.4yrs | no data | 0.059% $ 2.1m | |
Vice President of Treasury & Investor Relations | no data | no data | no data | |
Chief People Officer | no data | no data | no data | |
Senior Advisor | 9yrs | US$1.09m | no data | |
President of Oscar Medical Group | 3.8yrs | no data | no data |
3.6yrs
Average Tenure
54yo
Average Age
Experienced Management: OSCR's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 1.8yrs | US$44.54m | no data | |
Co-Founder | 12.1yrs | US$854.00k | 1.5% $ 53.0m | |
Co-Founder & Vice Chairman | 3.9yrs | no data | no data | |
Independent Chairman | 3.9yrs | US$299.98k | 0.25% $ 9.0m | |
Independent Director | 2.1yrs | US$264.99k | no data | |
Independent Director | 3.9yrs | US$277.49k | 0.043% $ 1.5m | |
Director | 3.9yrs | no data | 0.32% $ 11.4m | |
Independent Director | 2.1yrs | US$249.99k | 0.021% $ 735.7k | |
Independent Director | 3.9yrs | US$259.96k | 0.010% $ 358.6k | |
Independent Director | 3.9yrs | US$259.99k | 0.020% $ 717.6k |
3.9yrs
Average Tenure
51.5yo
Average Age
Experienced Board: OSCR's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/06 05:14 |
End of Day Share Price | 2025/01/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Oscar Health, Inc. is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hua Ha | Baird |
Kevin Fischbeck | BofA Global Research |
Adam Ron | BofA Global Research |